SmithKline Beecham and SkyePharma have entered into a development and licensing agreement for a once-daily version of SKB’s anti-Parkinson’s disease drug, Requip (ropinirole), using SkyePharma’s Geomatrix oral deliv…
M2 PRESSWIRE-17 September 1999-SMITHKLINE BEECHAM: Smithkline Beecham and SkyePharma sign agreement to develop once daily Requip (C)1994-99 M2 COMMUNICATIONS LTD RDATE:150999 LONDON — SmithKline Beecham (SB) and SkyePharma PLC announced today that they have entered into a development and licensing agreement for a once-daily version of SB’s…
Requip XL (ropirinole extended release tablets) have been approved by the Food and Drug Administration for the treatment of the signs and symptoms of idiopathic Parkinson’s disease. It is the first and only oral once-daily non-ergot do…
M2 PRESSWIRE-30 July 1999-SMITHKLINE BEECHAM: New study shows early treatment with Parkinson’s drug Requip significantly reduces the risk of dyskinesias and is effective long-term (C)1994-99 M2 COMMUNICATIONS LTD RDATE:290799 Vancouver, Canada — Reports of Parkinson’s disease affecting public figures such as Janet Reno, Michael J.
Related Results
Requip for RLSRequip reduces risk of dyskinesiasRequip now has generic competitorsGSK’s Requip significantly imp…
SkyePharma - Update on Convertible Bonds and Current Trading
LONDON, UK, 8 July, 2008 - SkyePharma PLC (LSE: SKP) today provides an
update on progress with the convertible bonds and current trading.
Progress with convertible bon…
CHAPEL HILL, N.C., June 25 /PRNewswire/ — New research that explores the tactics and strategies that lead to successful product development, launch and management is now available in the Best Practice Database, an online research repository managed by research and consulti…
Most people who suffer from restless leg syndrome are tormented each night through this severe pain and leg motion. Drug companies want you to believe that they have a cure, but a simple look at the headlines will show what many restless leg sufferers are scared of:
Mirapex: “Patients taking certain medicines to treat Parkinson’s disease or RLS, including Mirapex… have reported problems wi…
La Plaza de Armas de Arequipa constituye el ncleo de la ciudad, donde se encuentra la catedral, considerada como uno de los primeros monumentos religiosos del siglo XVII en el lugar.
Construida en sillar, es el templo ms importante de la localidad por varios motivos. Por ser sede de la jerarqua eclesistica. Porque su existencia est atada a la h…
Evidence of Permax heart valve damage has increased following a new study published in the March 2007 issue of the medical journal Archives of Neurology. This study provides further support of the problems linked to Permax. Heart valve damage was found to increase with long-term use of the drug. The purpose of this study was to compare Permax patients with those treated with the drugs Mirapex and …
